Met Life Investment Management, LLC Immuno Gen, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

54 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $30,315 - $72,868	-2,433 Reduced 1.9%	125,461 $3.72 Million
Q3 2023 May 09, 2024	BUY	$14.09 - $19.87 $245,870 - $346,731	17,450 Added 15.8%	127,894 $2.03 Million
Q2 2023 Apr 29, 2024	BUY	$3.75 - $20.05 $479,602 - $2.56 Million	127,894 New	127,894 $2.41 Million
Q2 2023 Aug 10, 2023	BUY	$3.75 - $20.05 $65,437 - $349,872	17,450 Added 15.8%	127,894 $2.41 Million
Q1 2023 May 09, 2024	BUY	$3.67 - $4.92 $405,329 - $543,384	110,444 New	110,444 $424 Million
Q3 2022 May 10, 2024	BUY	$4.48 - $6.47 $43,308 - $62,545	9,667 Added 9.59%	110,444 $527,000
Q3 2022 Mar 22, 2023	BUY	$4.48 - $6.47 $43,308 - $62,545	9,667 Added 9.59%	110,444 $527,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $43,308 - $62,545	9,667 Added 9.59%	110,444 $528,000
Q2 2022 May 10, 2024	SELL	$3.15 - $5.76 $24,251 - $44,346	-7,699 Reduced 7.1%	100,777 $453,000
Q2 2022 Jun 20, 2023	SELL	$3.15 - $5.76 $30,451 - $55,681	-9,667 Reduced 8.75%	100,777 $453,000
Q2 2022 Mar 22, 2023	SELL	$3.15 - $5.76 $24,251 - $44,346	-7,699 Reduced 7.1%	100,777 $453,000
Q2 2022 Aug 11, 2022	SELL	$3.15 - $5.76 $24,251 - $44,346	-7,699 Reduced 7.1%	100,777 $453,000
Q1 2022 May 10, 2024	BUY	$4.26 - $7.48 $462,107 - $811,400	108,476 New	108,476 $516,000
Q1 2022 Jun 20, 2023	SELL	$4.26 - $7.48 $8,383 - $14,720	-1,968 Reduced 1.78%	108,476 $516,000
Q1 2022 Mar 22, 2023	BUY	$4.26 - $7.48 $164,772 - $289,318	38,679 Added 55.42%	108,476 $516,000
Q1 2022 May 12, 2022	BUY	$4.26 - $7.48 $164,772 - $289,318	38,679 Added 55.42%	108,476 $516,000
Q4 2021 May 17, 2024	BUY	$4.75 - $7.5 $50,141 - $79,170	10,556 Added 17.82%	69,797 $517,000
Q4 2021 Jun 21, 2023	SELL	$4.75 - $7.5 $193,073 - $304,852	-40,647 Reduced 36.8%	69,797 $517,000
Q4 2021 Mar 22, 2023	BUY	$4.75 - $7.5 $50,141 - $79,170	10,556 Added 17.82%	69,797 $517,000
Q4 2021 Feb 15, 2022	BUY	$4.75 - $7.5 $50,141 - $79,170	10,556 Added 17.82%	69,797 $518,000
Q3 2021 May 17, 2024	SELL	$5.02 - $6.59 $72,574 - $95,271	-14,457 Reduced 19.62%	59,241 $335,000
Q3 2021 Jun 21, 2023	SELL	$5.02 - $6.59 $257,039 - $337,427	-51,203 Reduced 46.36%	59,241 $335,000
Q3 2021 Mar 22, 2023	SELL	$5.02 - $6.59 $72,574 - $95,271	-14,457 Reduced 19.62%	59,241 $335,000
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $72,574 - $95,271	-14,457 Reduced 19.62%	59,241 $336,000
Q2 2021 Jun 21, 2023	SELL	$5.79 - $8.6 $212,759 - $316,015	-36,746 Reduced 33.27%	73,698 $485,000
Q1 2021 May 17, 2024	BUY	$6.5 - $10.53 $479,037 - $776,039	73,698 New	73,698 $596,000
Q1 2021 Jun 26, 2023	SELL	$6.5 - $10.53 $238,849 - $386,935	-36,746 Reduced 33.27%	73,698 $597 Million
Q1 2021 Mar 22, 2023	BUY	$6.5 - $10.53 $93,379 - $151,273	14,366 Added 24.21%	73,698 $596,000
Q1 2021 May 14, 2021	BUY	$6.5 - $10.53 $93,379 - $151,273	14,366 Added 24.21%	73,698 $597,000
Q4 2020 May 24, 2024	BUY	$3.7 - $7.66 $12,324 - $25,515	3,331 Added 5.95%	59,332 $382,000
Q4 2020 Jun 22, 2023	SELL	$3.7 - $7.66 $189,114 - $391,517	-51,112 Reduced 46.28%	59,332 $382,000
Q4 2020 Mar 22, 2023	BUY	$3.7 - $7.66 $12,324 - $25,515	3,331 Added 5.95%	59,332 $382,000
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $12,324 - $25,515	3,331 Added 5.95%	59,332 $383,000
Q3 2020 May 24, 2024	SELL	$3.45 - $4.89 $74,171 - $105,130	-21,499 Reduced 27.74%	56,001 $202 Million
Q3 2020 Jun 26, 2023	SELL	$3.45 - $4.89 $187,828 - $266,226	-54,443 Reduced 49.29%	56,001 $201,000
Q3 2020 Mar 22, 2023	SELL	$3.45 - $4.89 $74,171 - $105,130	-21,499 Reduced 27.74%	56,001 $201,000
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $74,171 - $105,130	-21,499 Reduced 27.74%	56,001 $202,000
Q2 2020 May 24, 2024	BUY	$3.32 - $5.34 $257,300 - $413,850	77,500 New	77,500 $357 Million
Q2 2020 Jun 26, 2023	SELL	$3.32 - $5.34 $109,374 - $175,920	-32,944 Reduced 29.83%	77,500 $356,000
Q1 2020 Jul 12, 2023	SELL	$2.12 - $6.8 $69,841 - $224,019	-32,944 Reduced 29.83%	77,500 $264,000
Q1 2020 Mar 22, 2023	BUY	$2.12 - $6.8 $37,638 - $120,727	17,754 Added 29.72%	77,500 $264,000
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $37,638 - $120,727	17,754 Added 29.72%	77,500 $264,000
Q4 2019 Jul 12, 2023	SELL	$2.25 - $5.8 $114,070 - $294,048	-50,698 Reduced 45.9%	59,746 $305,000
Q3 2019 Jul 12, 2023	SELL	$2.22 - $3.39 $112,549 - $171,866	-50,698 Reduced 45.9%	59,746 $144,000
Q2 2019 Jul 12, 2023	SELL	$1.8 - $3.3 $91,256 - $167,303	-50,698 Reduced 45.9%	59,746 $129,000
Q1 2019 Jul 13, 2023	SELL	$2.41 - $5.91 $122,182 - $299,625	-50,698 Reduced 45.9%	59,746 $161,000
Q4 2018 Jul 13, 2023	SELL	$3.94 - $9.7 $199,750 - $491,770	-50,698 Reduced 45.9%	59,746 $286,000
Q4 2018 Mar 22, 2023	SELL	$3.94 - $9.7 $144,676 - $356,184	-36,720 Reduced 38.07%	59,746 $286,000
Q4 2018 Feb 14, 2019	SELL	$3.94 - $9.7 $144,676 - $356,184	-36,720 Reduced 38.07%	59,746 $287,000
Q3 2018 Jul 13, 2023	SELL	$8.6 - $11.26 $436,002 - $570,859	-50,698 Reduced 45.9%	59,746 $565,000
Q3 2018 Mar 22, 2023	SELL	$8.6 - $11.26 $120,210 - $157,392	-13,978 Reduced 12.66%	96,466 $913,000
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $315,792 - $413,467	36,720 Added 61.46%	96,466 $914,000
Q2 2018 Aug 15, 2018	BUY	$9.52 - $12.15 $130,681 - $166,783	13,727 Added 29.83%	59,746 $581,000
Q4 2017 Feb 15, 2018	BUY	$5.07 - $7.92 $233,316 - $364,470	46,019	46,019 $295,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account